Related references
Note: Only part of the references are listed.Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis
P. Coto-Segura et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy
Christopher E. M. Griffiths et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Lam C. Tsoi et al.
NATURE COMMUNICATIONS (2015)
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab
M. Talamonti et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis
Catherine T. Jordan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011
S. J. Meggitt et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal et al.
LANCET (2002)
Share Paper
